首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
RegorafenibMyasthenia gravis: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2023年
/ 1953卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-023-37785-9
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:350 / 350
相关论文
共 50 条
[31]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2017,
1662
(1)
: 293
-
293
[32]
DurvalumabMyasthenia gravis: case report
Reactions Weekly,
2024,
2029
(1)
: 244
-
244
[33]
IpilimumabMyasthenia gravis: case report
Reactions Weekly,
2018,
1701
(1)
: 165
-
165
[34]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2019,
1764
(1)
: 268
-
268
[35]
ElasomeranMyasthenia gravis: case report
Reactions Weekly,
2022,
1929
(1)
: 271
-
271
[36]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2021,
1878
(1)
: 434
-
434
[37]
AlemtuzumabMyasthenia gravis: case report
Reactions Weekly,
2020,
1802
(1)
: 21
-
21
[38]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2017,
1650
(1)
: 226
-
226
[39]
MacitentanMyasthenia gravis : case report
Reactions Weekly,
2024,
2017
(1)
: 272
-
272
[40]
PembrolizumabMyasthenia gravis: case report
Reactions Weekly,
2020,
1787
(1)
: 412
-
412
←
1
2
3
4
5
→